Neuroendocrine tumors of the pancreas
暂无分享,去创建一个
[1] D. Klimstra,et al. The value of splenic preservation with distal pancreatectomy. , 2002, Archives of surgery.
[2] T. Obara,et al. Laparoscopic ultrasonography for resection of insulinomas. , 2001, Surgery.
[3] A B Grossman,et al. MRI of pancreatic neuroendocrine tumours. , 2001, The British journal of radiology.
[4] J. Norton,et al. Intraoperative ultrasound and preoperative localization detects all occult insulinomas; discussion 1025-6. , 2001, Archives of surgery.
[5] L. Fernández‐Cruz,et al. Laparoscopic pancreatic surgery in patients with neuroendocrine tumours: indications and limits. , 2001, Best practice & research. Clinical endocrinology & metabolism.
[6] F. Collins,et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] Yoshinobu Sato,et al. Evaluation of Splenic Circulation after Spleen-Preserving Distal Pancreatectomy by Dividing the Splenic Artery and Vein , 2000, Digestive Surgery.
[8] S. Fan,et al. Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas * ** , 2000 .
[9] G. Kazemier,et al. Laparoscopic detection and resection of insulinomas. , 2000, Surgery.
[10] S. Fan,et al. Value of intra‐arterial calcium‐stimulated venous sampling for regionalization of pancreatic insulinomas , 2000, Surgery.
[11] M. Monden,et al. Evaluation of preoperative and intraoperative arterial stimulation and venous sampling for diagnosis and surgical resection of insulinoma. , 1999, Surgery.
[12] O. Clark,et al. Localization of insulinomas. , 1999, Archives of surgery.
[13] M. Barbacid,et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia , 1999, Nature Genetics.
[14] P. Ruszniewski,et al. Prognostic Factors in Patients With Zollinger-Ellison Syndrome and Multiple Endocrine Neoplasia Type 1 , 1999 .
[15] H. Northrup,et al. Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria , 1998, Journal of child neurology.
[16] S. Libutti,et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. , 1998, The American journal of pathology.
[17] S. Fan,et al. Pancreatic Insulinomas: A 15-Year Experience , 1997 .
[18] M. Gagner,et al. Early experience with laparoscopic resections of islet cell tumors. , 1996, Surgery.
[19] E. Bodner,et al. Is there a role for laparoscopic ultrasonography (LUS)? , 1995, Surgical laparoscopy & endoscopy.
[20] J. Charboneau,et al. Reoperative insulinomas, 1927 to 1992: an institutional experience. , 1993, Surgery.
[21] S. Lipsitz,et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. , 1992, The New England journal of medicine.
[22] A. Warshaw. Conservation of the spleen with distal pancreatectomy. , 1988, Archives of surgery.
[23] J. Norton,et al. Intraoperative Ultrasonographic Localization of Islet Cell Tumors: A Prospective Comparison to Palpation , 1988, Annals of surgery.
[24] F. Service,et al. The Surgical Aspects of Insulinomas , 1979, Annals of surgery.
[25] S. Carter,et al. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. , 1973, Annals of internal medicine.
[26] A. Cuschieri,et al. Localization of insulinoma by laparoscopic infragastric inspection of the pancreas and contact ultrasonography. , 1993, Surgical oncology.
[27] J. Norton,et al. Insulinomas: localization with selective intraarterial injection of calcium. , 1991, Radiology.